Skip to main content
SpringerLink
Log in

Cost-effectiveness of the MitraClip device in secondary mitral regurgitation: comment upon the article by Estler et al.

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

The Original Article was published on 27 May 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References:

  1. MJ Mack COAPT Three-year outcomes from a randomized trial of transcatheter mitral valve leaflet approximation in patients with heart failure and secondary mitral regurgitation. TCT (2019)

  2. Mack, M.J., Lindenfeld, J., Abraham, W.T., et al.: 3-Year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol 77(8), 1029–1040 (2021)

    Article  PubMed  Google Scholar 

  3. Estler, B., Rudolph, V., Seleznova, Y., et al.: Cost-effectiveness of the mitraclip device in German heart failure patients with secondary mitral regurgitation. Eur J Health Econ (2022). https://doi.org/10.1007/s10198-022-01476-4

    Article  PubMed  PubMed Central  Google Scholar 

  4. Stone, G.W., Lindenfeld, J., Abraham, W.T., et al.: Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379(24), 2307–2318 (2018)

    Article  PubMed  Google Scholar 

  5. Cohen, D.J., Wang, K., Magnuson, E., et al.: Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation. Heart 108(9), 717–724 (2022)

    Article  PubMed  Google Scholar 

  6. Baron, S.J., Wang, K., Arnold, S.V., et al.: Cost-effectiveness of transcatheter mitral valve repair versus medical therapy in patients with heart failure and secondary mitral regurgitation: results from the COAPT trial. Circulation 140(23), 1881–1891 (2019)

    Article  PubMed  Google Scholar 

  7. Shore, J., Russell, J., Frankenstein, L., et al.: An analysis of the cost-effectiveness of transcatheter mitral valve repair for people with secondary mitral valve regurgitation in the UK. J Med Econ 11, 1–20 (2020)

    Google Scholar 

  8. Tai, T.A.: Immature survival data for cancer drugs impacts NICE decisions. PharmacoEcon Outcomes News. 869(1), 16–16 (2021)

    Article  Google Scholar 

  9. Heart valve disease presenting in adults: investigation and management Cost-utility analysis Transcatheter Mitral edgeto-edge repair for inoperable patients NICE guideline NG2082021. https://www.nice.org.uk/guidance/ng208/evidence/mitraclip-economic-analysis-pdf-10890775261

  10. Adamo, M., Fiorelli, F., Melica, B., et al.: COAPT-like profile predicts long-term outcomes in patients with secondary mitral regurgitation undergoing mitraclip implantation. JACC Cardiovasc Interv. 14(1), 15–25 (2021)

    Article  PubMed  Google Scholar 

  11. Velu, J.F., Kortlandt, F.A., Hendriks, T., et al.: Comparison of outcome after percutaneous mitral valve repair with the mitraclip in patients with versus without atrial fibrillation. Am J Cardiol. 120(11), 2035–2040 (2017)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Warwick Medical School, University of Warwick, Gibbet Hill Road, Coventry, CV47AL, UK

    Martin Connock & Xavier Armoiry

  2. School of Pharmacy (ISPB)/UMR CNRS 5510 MATEIS/Edouard Herriot Hospital, Pharmacy Department, University of Lyon, Public Health Department, Claude Bernard University Lyon 1, 8 avenue Rockefeller, 69008, Lyon, France

    Xavier Armoiry

Authors
  1. Martin Connock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xavier Armoiry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xavier Armoiry.

Ethics declarations

Conflict of interest

The authors have read the journal's policy and declare the following competing interests: XA is a member of the steering committee of the Mitra-FR study. MC has nothing to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Connock, M., Armoiry, X. Cost-effectiveness of the MitraClip device in secondary mitral regurgitation: comment upon the article by Estler et al.. Eur J Health Econ 24, 783–784 (2023). https://doi.org/10.1007/s10198-022-01508-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-022-01508-z

Keywords

Search

Navigation